A detailed history of Boxer Capital, LLC transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Boxer Capital, LLC holds 811,627 shares of TARA stock, worth $2.1 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
811,627
Previous 209,227 287.92%
Holding current value
$2.1 Million
Previous $839,000 101.19%
% of portfolio
0.09%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.96 - $4.14 $1.18 Million - $2.49 Million
602,400 Added 287.92%
811,627 $1.69 Million
Q3 2020

Nov 16, 2020

BUY
$16.76 - $31.89 $3.51 Million - $6.67 Million
209,227 New
209,227 $3.52 Million

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $29.2M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.